{"transactions":[{"id":919654,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67770,"kind":"person","name":"Lutzker Stuart","position":1,"cik":"0002009257","reported_name":"Lutzker Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-04T20:43:08.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":22.67,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-010477","document":"tm265104-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009257/000110465926010477/tm265104-3_4seq1.xml","form_type":"4"}},{"id":1267699,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67770,"kind":"person","name":"Lutzker Stuart","position":1,"cik":"0002009257","reported_name":"Lutzker Stuart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:26:40.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 3, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":27.56,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-25-014172","document":"tm256714-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009257/000110465925014172/tm256714-4_4seq1.xml","form_type":"4"}}]}